The ketogenic diet added to usual care may offer a small benefit for treatment-resistant depression, the authors concluded.

Once-weekly subcutaneous tirzepatide may not raise risk for depression compared with placebo, according to a post hoc analysis of the SURMOUNT trials. As Healio previously reported, in January the FDA ...

For people with depression who aren’t getting adequate relief from medication, new research suggests a high-fat, low-carb ...

A comprehensive analysis of data spanning fifteen years reveals that depression symptoms have increased among college ...

USA: Researchers have found that once-weekly subcutaneous tirzepatide administered for 72 weeks does not increase the risk of ...

Programs like “Stay Well” in the UK and telehealth applications such as “Headspace” and “Calm” can serve as models for ...

PINELLAS COUNTY, Fla. — Florida Department of Transportation contractors completed work early Friday on a depression on Curlew Road. The roadway has been reopened. A depression opened up at the ...